We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmaker Warned for Unapproved Promotion, AE Reporting Failures
Drugmaker Warned for Unapproved Promotion, AE Reporting Failures
December 2, 2011
Crescendo Therapeutics has been warned for marketing a scar-removal drug lacking FDA approval and without a documented postmarket adverse drug experience (PADE) reporting system.